Jaguar Health (JAGX) Gains from Investment Securities (2016 - 2025)
Jaguar Health (JAGX) has disclosed Gains from Investment Securities for 11 consecutive years, with -$134000.0 as the latest value for Q3 2025.
- Quarterly Gains from Investment Securities fell 13400100.0% to -$134000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$418000.0 through Dec 2025, down 245.14% year-over-year, with the annual reading at $181338.0 for FY2025, 493.03% up from the prior year.
- Gains from Investment Securities for Q3 2025 was -$134000.0 at Jaguar Health, down from -$22000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $3.0 million in Q1 2022, with the low at -$1.4 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is $421745.7, with a median of $10000.0 recorded in 2023.
- The sharpest move saw Gains from Investment Securities skyrocketed 16626.19% in 2022, then plummeted 13400100.0% in 2025.
- Over 5 years, Gains from Investment Securities stood at $128000.0 in 2021, then crashed by 1189.84% to -$1.4 million in 2022, then surged by 111.68% to $163000.0 in 2023, then plummeted by 98.77% to $2000.0 in 2024, then plummeted by 6800.0% to -$134000.0 in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$134000.0, -$22000.0, and -$262000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.